COVID-19 ve Kardiyovasküler Hastalıklar
Abstract
Keywords
References
- 1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020 Feb) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 17: 105924
- 2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020; 323: 1239–42.
- 3. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 May; 109: 531–8.
Details
Primary Language
Turkish
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Muhammed Demir
*
This is me
Türkiye
Mehmet Özbek
This is me
Türkiye
Hakkı Şimşek
This is me
Türkiye
Publication Date
September 1, 2021
Submission Date
September 15, 2021
Acceptance Date
September 29, 2021
Published in Issue
Year 2021 Volume: 48
Cited By
Comparison of the Efficacy and Safety Profiles of Different P2Y12 Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction in the COVID-19 Era
Cureus
https://doi.org/10.7759/cureus.43829COVID-19 Pandemisinde Kalp Yetmezliği Hastalarının COVID-19 Korkusu ve Anksiyete Düzeylerinin İncelenmesi
Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
https://doi.org/10.51754/cusbed.1248715